2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers Lain Anderson TJ Bilodeau Read more
Related Practice Life Sciences & Pharma In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations. 01052021090143
Executive Insights Mental and Behavioral Health Psychedelics and Psychotherapy: A Treatment Paradigm for the Future? March 27, 2024
Published Articles Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies February 27, 2024
Published Articles Marketing & Sales Understanding the ‘Cookie Apocalypse’ and Its Impact on Online Advertising February 23, 2024
Special Report Life Sciences & Pharma Medical Communications Trends: Outsourcing Implications and Transformation June 22, 2023